← Leaderboards
Michael Y Tsai
University Of Wisconsin-Madison
$1,523,256
Attributed
$4,569,767
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2012–16$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$4,569,767 · 1
By mechanism
R01$4,569,767 · 1
Top collaborators
- Barbara E Klein5 shared
- Ronald Klein5 shared
Most similar at University Of Wisconsin-Madison
Same institution · by research overlap
- Zachary Campbell$4,686,519
- Xin Huang$4,106,913
- Olachi Joy Mezu-Ndubuisi$1,188,910
- Ismail S Zaitoun$2,391,108
- Ronald Danis$5,567,046
Others in their field
Top investigators on “Advanced Glycosylation End Products”
- Ann Marie Schmidt · Beckman Research Institute/City Of Hope$16,947,325
- Jose A Luchsinger · Columbia University Health Sciences$11,327,382
- Gary E Gibson · Winifred Masterson Burke Med Res Inst$10,842,701
- Howard Feldman · University Of California, San Diego$10,098,461
- Ram H Nagaraj · Case Western Reserve University$9,627,678
- Michal Schnaider Beeri · Icahn School Of Medicine At Mount Sinai$7,313,968
Research focus
Advanced Glycosylation End ProductsAge-YearsAmputationAntioxidantsAreaAtherosclerosisBlood PressureBlood Pressure RegulationCaliberCandidate Disease GeneCardiovascular DiseasesCaringCarotid ArteriesCharacteristicsChargeCognitionCohortCohort StudiesComplications Of Diabetes MellitusCountyCreatinineDiabetes MellitusDiabetic NephropathyAbstracting
Grant awards (5)
Epidemiology of Retinopathy and other Complications in Long Term Type 1 Diabetes$527,271
R01 · FY2016 · EY
Epidemiology of Retinopathy and other Complications in Long Term Type 1 Diabetes$528,404
R01 · FY2015 · EY
Epidemiology of Retinopathy and other Complications in Long Term Type 1 Diabetes$620,227
R01 · FY2014 · EY
Epidemiology of Retinopathy and other Complications in Long Term Type 1 Diabetes$1,349,928
R01 · FY2013 · EY
Epidemiology of Retinopathy and other Complications in Long Term Type 1 Diabetes$1,543,937
R01 · FY2012 · EY